AZENMI

Swiss trademark · 644873 · Word mark · Deleted

Register entry

Registration number
644873
Application number
53223/2013
Status
Deleted
Type
Word mark
Filed
Mar 14, 2013
Registered
Jun 6, 2013
Published
Jun 6, 2013
Deleted
Oct 7, 2023
Reason
Not renewed
Priority
18.09.2012 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für den Humangebrauch für die Behandlung und Prävention von Fettleibigkeit, Diabetes, Inkontinenz, kardiovaskulären Erkrankungen, Erkrankungen und Störungen des zentralen Nervensystems, metabolischen Störungen, Schlaganfällen, Krebs, Entzündungen und entzündliche Erkrankungen, Atemwegs- und Infektionskrankheiten, Autoimmunerkrankungen, Organtransplantatabstossungen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 7, 2023

    Deleted, not renewed

    Published in Swissreg on 07.10.2023

  2. Jun 6, 2013

    Registered

    Published in Swissreg on 06.06.2013

Parties

Holder

Bristol-Myers Squibb Company

345 Park Avenue, New York, NY 10154, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.